Cyclacel Pharmaceuticals Inc

NASDAQ:CYCC   3:59:43 PM EDT
4.15
-0.01 (-0.24%)
Earnings Announcements

Cyclacel Pharmaceuticals Reports Q3 2020 Financial Results

Published: 11/11/2020 21:26 GMT
Cyclacel Pharmaceuticals Inc (CYCC) - Cyclacel Pharmaceuticals Reports Third Quarter 2020 Financial Results.
Cyclacel Pharmaceuticals Inc Qtrly Loss per Share $0.47.
Cyclacel Pharmaceuticals - Estimates That Cash Resources of $23.1 Million As of Sept 30, 2020 Will Fund Currently Planned Programs Through End of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.